Virax Biolabs Group Limited Gains 83.31%
Tue, Mar 07, 2023 at 07:10 PM
Virax Biolabs Group Limited (VRAX:NASDAQ) soared at $1.21, a gain of 83.3%. On Tue, Mar 07, 2023, VRAX:NASDAQ hit a New 2-Week High of $1.21. The stock appeared on our News Catalysts scanner on Tue, Mar 07, 2023 at 09:42 AM in the 'BIOTECH' category. From Wed, Feb 22, 2023, the stock recorded 55.56% Up Days and 40.00% Green Days
The stock spiked on Tue, Mar 07, 2023 at $1.6 with a volume of 68M+.
About Virax Biolabs Group Limited (VRAX:NASDAQ)
Virax Biolabs Group Ltd is a innovative biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases with a particular interest in the field of...
Top 10 Gainers:
- Virax Biolabs Group Limited (VRAX:NASDAQ), 83.31%
- WW International, Inc. (WW:NASDAQ), 79.07%
- Protagonist Therapeutics, Inc. (PTGX:NASDAQ), 51.91%
- ThredUp Inc. (TDUP:NASDAQ), 51.23%
- Mercurity Fintech Holding Inc. (MFH:NASDAQ), 43.33%
- Bellerophon Therapeutics, Inc. (BLPH:NASDAQ), 42.45%
- Decarbonization Plus Acquisition Corporation IV (DCRD:NASDAQ), 40.52%
- Siyata Mobile Inc. (SYTA:NASDAQ), 32.65%
- Etao International Co. Ltd. (ETAO:NASDAQ), 30.74%
- Peak Bio Inc Com (PKBO:NASDAQ), 30.45%